Veracyte ROA 2012-2018 | VCYT

Current and historical return on assets (ROA) values for Veracyte (VCYT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Veracyte ROA for the three months ending June 30, 2018 was -41.36%.
Veracyte ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-06-30 $-0.03B $0.07B -40.13%
2018-03-31 $-0.03B $0.07B -38.51%
2017-12-31 $-0.03B $0.08B -34.88%
2017-09-30 $-0.03B $0.08B -28.42%
2017-06-30 $-0.03B $0.09B -28.41%
2017-03-31 $-0.03B $0.09B -34.22%
2016-12-31 $-0.03B $0.10B -37.58%
2016-09-30 $-0.04B $0.07B -46.05%
2016-06-30 $-0.04B $0.08B -48.25%
2016-03-31 $-0.04B $0.08B -44.58%
2015-12-31 $-0.03B $0.08B -46.26%
2015-09-30 $-0.03B $0.08B -47.89%
2015-06-30 $-0.03B $0.08B -48.00%
2015-03-31 $-0.03B $0.06B -47.69%
2014-12-31 $-0.03B $0.07B -43.32%
2014-09-30 $-0.03B $0.07B -38.36%
2014-06-30 $-0.03B $0.07B -42.62%
2014-03-31 $-0.03B $0.07B -49.26%
2013-12-31 $-0.03B $0.08B -76.34%
2013-09-30 $-0.02B $0.02B -149.02%
2013-06-30 $-0.02B $0.03B -266.67%
2013-03-31 $-0.01B $0.00B inf%
2012-12-31 $-0.01B $0.00B -200.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.353B $0.072B
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $91.495B 21.95
Intuitive Surgical (ISRG) United States $57.358B 56.66
Edwards Lifesciences (EW) United States $30.449B 34.30
Fresenius Medical Care (FMS) Germany $24.786B 17.51
IDEXX Laboratories (IDXX) United States $18.911B 57.47
ABIOMED (ABMD) United States $16.264B 133.24
DexCom (DXCM) United States $11.398B 0.00
Teleflex (TFX) United States $11.146B 26.51
Hologic (HOLX) United States $11.111B 18.90
Varian Medical Systems (VAR) United States $9.538B 24.01
STERIS (STE) United Kingdom $9.020B 24.81
Masimo (MASI) United States $6.006B 39.99
LivaNova (LIVN) United Kingdom $5.520B 32.92
Integra LifeSciences Holdings (IART) United States $5.328B 27.57
Globus Medical (GMED) United States $5.162B 34.34
Penumbra (PEN) United States $4.709B 428.03
Inogen (INGN) United States $4.171B 110.38
Cantel Medical (CMD) United States $3.475B 35.01
Wright Medical Group (WMGI) Netherlands $2.936B 0.00
Halyard Health (AVNS) United States $2.817B 23.18
Integer Holdings (ITGR) United States $2.376B 21.52
Glaukos (GKOS) United States $2.094B 0.00
Opko Health (OPK) United States $2.010B 0.00
Tandem Diabetes Care (TNDM) United States $1.921B 0.00
Mazor Robotics (MZOR) Israel $1.525B 0.00
Nevro (NVRO) United States $1.515B 0.00
AxoGen (AXGN) United States $1.284B 0.00
Luminex (LMNX) United States $1.267B 37.38
K2Ms (KTWO) United States $1.192B 0.00
Tactile Systems Technology (TCMD) United States $1.182B 201.47
CryoLife (CRY) United States $1.176B 103.19
Orthofix (OFIX) United States $1.065B 32.44
Natus Medical (BABY) United States $1.037B 22.00
Accelerate Diagnostics (AXDX) United States $0.906B 0.00
Intersect ENT (XENT) United States $0.855B 0.00
AngioDynamics (ANGO) United States $0.748B 26.16
ViewRay (VRAY) United States $0.714B 0.00
Mesa Laboratories (MLAB) United States $0.699B 43.21
Sientra (SIEN) United States $0.633B 0.00
Pacific Biosciences Of California (PACB) United States $0.578B 0.00
Neuronetics (STIM) United States $0.437B 0.00
OrthoPediatrics (KIDS) United States $0.420B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.414B 0.00
Quotient (QTNT) Switzerland $0.351B 0.00
GenMark Diagnostics (GNMK) United States $0.326B 0.00
Accuray (ARAY) United States $0.312B 0.00
Nuvectra (NVTR) United States $0.296B 0.00
Fluidigm (FLDM) United States $0.294B 0.00
RTI Surgical (RTIX) United States $0.290B 57.13
IRadimed (IRMD) United States $0.277B 99.89
SeaSpine Holdings (SPNE) United States $0.243B 0.00
T2 Biosystems (TTOO) United States $0.207B 0.00
Helius Medical Technologies (HSDT) United States $0.205B 0.00
Invuity (IVTY) United States $0.178B 0.00
Pulse Biosciences (PLSE) United States $0.163B 0.00
RA MEDICAL SYST (RMED) United States $0.162B 0.00
Apollo Endosurgery (APEN) United States $0.135B 0.00
Alphatec Holdings (ATEC) United States $0.133B 0.00
Ekso Bionics Holdings (EKSO) United States $0.123B 0.00
Viveve Medical (VIVE) United States $0.110B 0.00
Second Sight Medical Products (EYES) United States $0.105B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.090B 0.00
EDAP TMS (EDAP) France $0.077B 0.00
Biosig Technologies (BSGM) United States $0.077B 0.00
ConforMIS (CFMS) United States $0.059B 0.00
Restoration Robotics (HAIR) United States $0.056B 0.00
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Neovasc (NVCN) Canada $0.043B 0.00
Vermillion (VRML) United States $0.036B 0.00
Lianluo Smart (LLIT) China $0.035B 0.00
PAVmed (PAVM) United States $0.031B 0.00
Titan Medical (TMDI) Canada $0.028B 0.00
ReWalk Robotics (RWLK) Israel $0.027B 0.00
Dynatronics (DYNT) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
ENDRA Life Sciences (NDRA) United States $0.022B 0.00
Presbia (LENS) Ireland $0.021B 0.00
Nanovibronix (NAOV) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Bioanalytical Systems (BASI) United States $0.016B 0.00
Avinger (AVGR) United States $0.013B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Amedica (AMDA) United States $0.004B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00